======= BCR ======= == Gene Information == * **Official Symbol**: BCR * **Official Name**: BCR activator of RhoGEF and GTPase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=613|613]] * **UniProt**: [[https://www.uniprot.org/uniprot/P11274|P11274]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BCR&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BCR|Open PubMed]] * **OMIM**: [[https://omim.org/entry/151410|Open OMIM]] == Function Summary == * **Entrez Summary**: A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: GTPase-activating protein for RAC1 and CDC42. Promotes the exchange of RAC or CDC42-bound GDP by GTP, thereby activating them. Displays serine/threonine kinase activity. {ECO:0000269|PubMed:1657398, ECO:0000269|PubMed:1903516}. |Bcr-Abl Oligo| |RhoGAP| |PH| |C2| |RhoGEF| |negative regulation of neutrophil degranulation| |negative regulation of blood vessel remodeling| |negative regulation of neutrophil activation| |negative regulation of respiratory burst| |regulation of neutrophil degranulation| |regulation of blood vessel remodeling| |negative regulation of cellular extravasation| |regulation of neutrophil activation| |negative regulation of myeloid leukocyte mediated immunity| |negative regulation of leukocyte degranulation| |regulation of respiratory burst| |definitive hemopoiesis| |postsynaptic density, intracellular component| |negative regulation of tissue remodeling| |negative regulation of regulated secretory pathway| |focal adhesion assembly| |cell-substrate adherens junction assembly| |regulation of cellular extravasation| |platelet-derived growth factor receptor signaling pathway| |negative regulation of exocytosis| |adherens junction assembly| |regulation of vascular permeability| |cell-substrate junction assembly| |negative regulation of leukocyte migration| |negative regulation of leukocyte mediated immunity| |regulation of leukocyte degranulation| |intracellular protein transmembrane transport| |neuromuscular process controlling balance| |negative regulation of reactive oxygen species metabolic process| |regulation of myeloid leukocyte mediated immunity| |protein transmembrane transport| |positive regulation of phagocytosis| |Rho guanyl-nucleotide exchange factor activity| |regulation of tissue remodeling| |kinase activity| |Schaffer collateral - CA1 synapse| |adherens junction organization| |regulation of phagocytosis| |activation of GTPase activity| |inner ear morphogenesis| |guanyl-nucleotide exchange factor activity| |neuromuscular process| |renal system process| |ear morphogenesis| |negative regulation of immune effector process| |cell-matrix adhesion| |negative regulation of inflammatory response| |regulation of Rho protein signal transduction| |negative regulation of immune response| |regulation of regulated secretory pathway| |cell junction assembly| |vascular process in circulatory system| |negative regulation of leukocyte activation| |regulation of reactive oxygen species metabolic process| |cellular response to lipopolysaccharide| |cell-substrate adhesion| |cellular response to molecule of bacterial origin| |protein autophosphorylation| |inner ear development| |regulation of leukocyte migration| |negative regulation of cell activation| |postsynaptic membrane| |homeostasis of number of cells| |negative regulation of secretion by cell| |regulation of leukocyte mediated immunity| |negative regulation of defense response| |cell junction organization| |cellular response to biotic stimulus| |ear development| |regulation of exocytosis| |negative regulation of secretion| |regulation of Ras protein signal transduction| |postsynaptic density| |sensory organ morphogenesis| |negative regulation of cell migration| |negative regulation of cell motility| |keratinocyte differentiation| |GTPase activator activity| |embryonic organ morphogenesis| |negative regulation of cellular component movement| |response to lipopolysaccharide| |epidermal cell differentiation| |small GTPase mediated signal transduction| |negative regulation of locomotion| |response to molecule of bacterial origin| |regulation of inflammatory response| |regulation of small GTPase mediated signal transduction| |glutamatergic synapse| |protein serine/threonine kinase activity| |negative regulation of response to external stimulus| |skin development| |blood circulation| |circulatory system process| |positive regulation of GTPase activity| |epidermis development| |embryonic organ development| |negative regulation of immune system process| |modulation of chemical synaptic transmission| |regulation of trans-synaptic signaling| |regulation of immune effector process| |regulation of GTPase activity| |negative regulation of transport| |actin cytoskeleton organization| |transmembrane receptor protein tyrosine kinase signaling pathway| |cellular response to lipid| |sensory organ development| |cell junction| |regulation of vesicle-mediated transport| |hemopoiesis| |embryonic morphogenesis| |actin filament-based process| |protein-containing complex| |regulation of leukocyte activation| |hematopoietic or lymphoid organ development| |regulation of cell activation| |immune system development| |epithelial cell differentiation| |response to bacterium| |enzyme linked receptor protein signaling pathway| |brain development| |regulation of secretion by cell| |regulation of defense response| |positive regulation of hydrolase activity| |head development| |regulation of secretion| |regulation of cell migration| |response to lipid| |regulation of cell motility| |cell adhesion| |biological adhesion| |negative regulation of developmental process| |animal organ morphogenesis| |protein phosphorylation| |embryo development| |central nervous system development| |regulation of locomotion| |positive regulation of transport| |intracellular protein transport| |regulation of cellular component movement| |cellular response to oxygen-containing compound| |regulation of anatomical structure morphogenesis| |regulation of response to external stimulus| |cytoskeleton organization| |epithelium development| |regulation of immune response| |regulation of cell cycle| |negative regulation of multicellular organismal process| |transmembrane transport| |regulation of hydrolase activity| |phosphorylation| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |nervous system process| |positive regulation of catalytic activity| |regulation of response to stress| |ATP binding| |protein transport| |intracellular transport| |peptide transport| |response to oxygen-containing compound| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |negative regulation of response to stimulus| |homeostatic process| |regulation of immune system process| |intracellular signal transduction| |tissue development| |positive regulation of molecular function| |regulation of intracellular signal transduction| |establishment of localization in cell| |nitrogen compound transport| |regulation of transport| |system process| |membrane| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 5/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|5/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9312 * **Expression level (log2 read counts)**: 8.21 {{:chemogenomics:nalm6 dist.png?nolink |}}